Your browser doesn't support javascript.
loading
Deglycosylation of PD-L1 by 2-deoxyglucose reverses PARP inhibitor-induced immunosuppression in triple-negative breast cancer.
Shao, Bin; Li, Chia-Wei; Lim, Seung-Oe; Sun, Linlin; Lai, Yun-Ju; Hou, Junwei; Liu, Chunxiao; Chang, Chiung-Wen; Qiu, Yufan; Hsu, Jung-Mao; Chan, Li-Chuan; Zha, Zhengyu; Li, Huiping; Hung, Mien-Chie.
Afiliação
  • Shao B; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center Houston, TX, USA.
  • Li CW; Key Laboratory of Carcinogenesis and Transformation Research (Ministry of Education), Department of Breast Oncology, Peking University Cancer Hospital & Institute Beijing 100142, P. R. China.
  • Lim SO; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center Houston, TX, USA.
  • Sun L; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center Houston, TX, USA.
  • Lai YJ; Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University West Lafayette, IN 47907, USA.
  • Hou J; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center Houston, TX, USA.
  • Liu C; Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Lung Cancer Institute, Tianjin Medical University General Hospital Tianjin, P. R. China.
  • Chang CW; Department of Neurology, McGovern Medical School, The University of Texas Health Science Center at Houston Houston, TX, USA.
  • Qiu Y; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center Houston, TX, USA.
  • Hsu JM; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center Houston, TX, USA.
  • Chan LC; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center Houston, TX, USA.
  • Zha Z; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center Houston, TX, USA.
  • Li H; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center Houston, TX, USA.
  • Hung MC; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center Houston, TX, USA.
Am J Cancer Res ; 8(9): 1837-1846, 2018.
Article em En | MEDLINE | ID: mdl-30323975
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article